# OnCo record fortplus (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/fortplus/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "fortplus", "NCT05045664" ;
  schema:name "FORTplus"@en ;
  schema:alternateName "FORTplus trial"@en, "Early Stage Follicular Lymphoma and Radiotherapy plus Anti-CD20 Antibody"@en ;
  schema:description "A trial testing whether a radiotherapy dose one sixth of the standard works as well for early follicular lymphoma when an antibody is given alongside it."@en ;
  schema:url <https://onco.cc/trials/fortplus/> ;
  schema:dateModified "2026-10-01"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT05045664>, <https://doi.org/10.1016/S1470-2045(20)30686-0> ;
  onco:status "active" ;
  onco:tag "lymphoma-evidence" ;
  onco:phase "3" ;
  schema:startDate "2022-07-06" ;
  onco:cancers <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/radiation/>, <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/terms/radiotherapy/>, <https://onco.cc/technologies/monoclonal-antibody/> ;
  onco:targets <https://onco.cc/targets/cd20/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/obinutuzumab/> ;
  onco:terms <https://onco.cc/terms/complete-response/>, <https://onco.cc/terms/non-inferiority/> ;
  onco:trials <https://onco.cc/trials/trog-99-03/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-surgery-radiation-innovation/>, <https://onco.cc/bottlenecks/b-global-access/>, <https://onco.cc/bottlenecks/b-toxicity-qol/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-fort-4gy-vs-24gy-indolent-lymphoma-hoskin-lancet-oncol-2014/>, <https://onco.cc/key-papers/paper-fort-long-term-follow-up-hoskin-lancet-oncol-2021/> .